These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10850311)

  • 21. [The role of gallium-67 citrate scintigraphy in gastro-intestinal malignant lymphoma].
    Kataoka M; Tsuda T; Kawamura M; Itoh H; Komatsu A; Mogami H; Tanada S; Iio A; Hamamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):155-63. PubMed ID: 2362795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
    Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
    J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of gallium 67 scanning in the management of Hodgkin's disease.
    Raby N; Ineson N
    Br J Clin Pract; 1987 Jan; 41(1):553-6. PubMed ID: 3663456
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of gallium-67 scintigraphy to monitor tumor response rates and predict long-term clinical outcome in patients with lymphoma.
    Tuli MM; Al-Shemmari SH; Ameen RM; Al-Muhanadi S; Al-Huda FA; Ballani N; Khoshi M; Al-Enezi F; Bajciova V; Mottl H
    Clin Lymphoma; 2004 Jun; 5(1):56-61. PubMed ID: 15245609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
    Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ
    J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
    Larcos G; Farlow DC; Antico VF; Gruenewald SM; Boyages J
    Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of low-dose gallium-67 imaging in detection of non-Hodgkin's lymphoma recurrence.
    Nakayama M; Sakahara H; Minowa Y; Sasai K; Ishigaki T; Saga T; Nakamoto Y; Yao Z; Hiraoka M; Sakai K; Konishi J
    Radiat Med; 1997; 15(2):79-83. PubMed ID: 9192431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing biodistribution of gallium during G-CSF treatment in non- Hodgkin's disease.
    Maffioli LS; Castellani MR; Bombardieri E; Devizzi L; Draisma A; Pauwels E
    Eur J Nucl Med; 1999 Jan; 26(1):68-9. PubMed ID: 10048953
    [No Abstract]   [Full Text] [Related]  

  • 29. [False-positive findings of 67-gallium scintigraphy in staging/restaging of malignant lymphoma].
    Bihl H; Kimmig B
    Rofo; 1987 Feb; 146(2):172-7. PubMed ID: 3029830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of flow cytometric parameters and transferrin receptors with gallium-67 scintigraphic images in lymphoma patients.
    Kiratli PO; Canpinar H; Ruacan S; Kansu E
    Nucl Med Commun; 2000 Oct; 21(10):925-31. PubMed ID: 11130333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gallium scanning in the management of mediastinal Hodgkin's disease.
    Wylie BR; Southee AE; Joshua DE; McLaughlin AF; Gibson J; Hutton BF; Morris JG; Kronenberg H
    Eur J Haematol; 1989 Apr; 42(4):344-7. PubMed ID: 2721659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
    Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
    Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does gallium uptake in the pulmonary hila predict involvement by non-Hodgkin's lymphoma?
    Champion PE; Groshar D; Hooper HR; Palmer M; Catz Z; Belch A; McEwan A
    Nucl Med Commun; 1992 Oct; 13(10):730-7. PubMed ID: 1491837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of gallium imaging after therapy for Hodgkin's disease.
    Bogart JA; Chung CT; Mariados NF; Vermont AI; Lemke SM; Grethlein S; Graziano SL
    Cancer; 1998 Feb; 82(4):754-9. PubMed ID: 9477109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gallium scans for residual Hodgkin's disease.
    Goldsmith GH
    J Clin Oncol; 1994 Jun; 12(6):1336. PubMed ID: 8201396
    [No Abstract]   [Full Text] [Related]  

  • 36. The accuracy of retroperitoneal ultrasonography in Hodgkin's disease and non-Hodgkin's lymphoma.
    Brascho DJ; Durant JR; Green LE
    Radiology; 1977 Nov; 125(2):485-7. PubMed ID: 910062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast metastasis of non-Hodgkin's lymphoma: evaluation with Ga-67 scintigraphy.
    Hama Y; Kosuda S; Uematsu M; Kusano S
    Clin Nucl Med; 2000 Jul; 25(7):549-50. PubMed ID: 10885701
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of 67 gallium-citrate in non-Hodgkin's lymphoma (author's transl)].
    Oshiumi Y; Nakayama C; Kamoi I; Ichiya Y; Matsuura K
    Rinsho Hoshasen; 1979; 24(10):1181-9. PubMed ID: 502070
    [No Abstract]   [Full Text] [Related]  

  • 39. Differentiation between residual cancer and thymic hyperplasia in malignant non-Hodgkin's lymphoma with somatostatin receptor scintigraphy.
    Rettenbacher L; Galvan G
    Clin Nucl Med; 1994 Jan; 19(1):64-5. PubMed ID: 8137590
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of unexpected gallium-67 uptake by sternum in non-Hodgkin's lymphoma with pleuritis.
    Ohta H; Ishii M; Sakashita T; Iwasaki H; Shiraishi T; Ikekubo K; Endo K; Konishi J
    Ann Nucl Med; 1988 Nov; 2(2):81-3. PubMed ID: 3275112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.